Google
Trusted Resources: News & Events
Latest announcements and gatherings
GBT Supports Sickle Cell Patients During COVID-19 Pandemic
Global Blood Therapeutics (GBT) is taking proactive measures to support public health efforts and sickle cell disease (SCD) patients during the global COVID-19 pandemic.
To help stem the spread of the coronavirus, the company is backing public health strategies, including social distancing. Specifically, GBT is temporarily prohibiting all field team in-person interactions, including visits to physicians, clinics, hospitals and payers.
GBT also seeks to assure SCD patients that GBT Source, the company’s support program for those prescribed Oxbryta, remains available to help with new enrollments and reimbursement, as well as financial, co-pay, treatment adherence, and refill support.
+myBinderRelated Content
-
CDC Updates, Expands List of People at Risk of Severe COVID-19 IllnessOlder adults and people with underlying ...
-
NORD/EURORDIS-Rare Diseases Europe Joint Statement on COVID-19 and Orphan Drug LegislationThe National Organization for Rare Disor...
-
MARAC Advisory Statement Regarding SCD Patients during the time of “Reopening” the U.S. EconomyMay 14, 2020—On Thursday April 16, 202...
-
Sickle Cell Disease Hotline | Cayenne Wellness Center and Sickle Cell Disease Education & AwarenessPatients living with Sickle Cell Disease...
-
You Should Get a COVID-19 Vaccine – Nepalihttps://www.youtube.com/watch?v=mdmgLDiY...
-
Patricia Frieson was more than the 1st COVID-19 death in Illinois. She was their sister.When she was 11, her parents, Dan and Ef...
-
You Should Get a COVID-19 Vaccine – Swahilihttps://www.youtube.com/watch?v=Cvl_R8sJ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.